CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 35 filers reported holding CONATUS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.99 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Q1 2021 | $0 | – | 0 | – | 0.00% | – |
Q4 2020 | $0 | – | 0 | – | 0.00% | – |
Q3 2020 | $0 | – | 0 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | – | 0 | – | 0.00% | – |
Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q4 2018 | $11,000 | -54.2% | 8,255 | +50.1% | 0.00% | 0.0% |
Q2 2018 | $24,000 | +50.0% | 5,500 | +59.2% | 0.00% | 0.0% |
Q1 2018 | $16,000 | 0.0% | 3,455 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $16,000 | -48.4% | 3,455 | -38.0% | 0.00% | 0.0% |
Q3 2017 | $31,000 | +93.8% | 5,575 | +106.5% | 0.00% | 0.0% |
Q2 2017 | $16,000 | +300.0% | 2,700 | +285.7% | 0.00% | – |
Q1 2017 | $4,000 | -50.0% | 700 | -56.2% | 0.00% | – |
Q4 2016 | $8,000 | +700.0% | 1,600 | +128.6% | 0.00% | – |
Q3 2016 | $1,000 | 0.0% | 700 | 0.0% | 0.00% | – |
Q2 2016 | $1,000 | -50.0% | 700 | 0.0% | 0.00% | – |
Q4 2015 | $2,000 | – | 700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 1,192,080 | $6,545,000 | 3.19% |
COURAGE CAPITAL MANAGEMENT LLC | 200,000 | $1,098,000 | 0.74% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 174,512 | $958,000 | 0.06% |
Family Management Corp | 14,000 | $77,000 | 0.05% |
EAM Investors, LLC | 62,752 | $345,000 | 0.05% |
FNY Managed Accounts LLC | 4,400 | $24,000 | 0.03% |
ACADIAN ASSET MANAGEMENT LLC | 1,090,397 | $5,988,000 | 0.03% |
REILLY FINANCIAL ADVISORS, LLC | 22,011 | $121,000 | 0.02% |
Alambic Investment Management, L.P. | 28,500 | $156,000 | 0.02% |
Caprock Group, LLC | 14,085 | $77,000 | 0.02% |